Scopia Capital Management L.P., 10% Owner at ACORDA THERAPEUTICS INC (ACOR), sold 123,714 shares at $16.27 ($2.0M) on 2018-12-13, disclosed to the SEC on 2018-12-17.
Open-market sale of $2.0M ACOR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.27 | 33,061 | $538K | 26.8% |
| 2 | $16.27 | 33,061 | $538K | 26.8% |
| 3 | $16.15 | 28,796 | $465K | 23.2% |
| 4 | $16.15 | 28,796 | $465K | 23.2% |
| Total | $16.21 avg | 123,714 | $2.0M | 100% |
| Filing → |
| ITRI | SELL | 2019-05-03 | $7.4M | — | Filing → |
| ITRI | SELL | 2019-05-01 | $4.4M | — | Filing → |
| ITRI | SELL | 2019-04-22 | $1.4M | — | Filing → |